mexiletine has been researched along with Anemia, Sickle Cell in 1 studies
Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadouh, NK | 1 |
| Lang, S | 1 |
| Shamoun, M | 1 |
| Scott, EL | 1 |
| Singh, SA | 1 |
| Smith, MA | 1 |
1 other study available for mexiletine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder.
Topics: Anemia, Sickle Cell; Autism Spectrum Disorder; Humans; Mexiletine; Pain, Intractable | 2022 |